TABLE 2 Clinical Information

From: T-Cell Lymphoma Presenting in the Breast: A Histologic, Immunophenotypic and Molecular Genetic Study of Four Cases

Case

Age/sex

Site

Diagnosis

Follow-Up

1

13/F

Lt breast

ALCL, CD30+, T-cell (ALK-1+, TIA-1+)

DOD 5 mo

2

56/F

Rt breast/axillary LN

PTCL, medium cell (βF1+, CD8+, TIA-1+)

DOD 3 mo

3

44/F

Lt breast/lung

NK/T (CD56+, TIA-1+, CD4−, CD8−)

DOD 18 mo

4

77/F

Rt breast

PTCL, large cell (CD4+, βF1+)

None

  1. F, female; Lt, left; Rt, right; LN, lymph node; ALCL, anaplastic large cell lymphoma; PTCL, peripheral T-cell lymphoma; ALK, anaplastic lymphoma kinase; TIA, T-cell intracellular antigen; NK/T, natural killer cell/T-cell lymphoma; DOD, died of disease; +, immunoreactive; −, negative.